指南与共识心脑血管急症中毒与环境急症

药物诱导QT间期延长及其急性过量后并发症病例报告与系列报告的指南

Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose.
指南 / 共识 · Clin Toxicol (Phila) · 2019-04-24
一句话结论临床毒理学协作组(CTC)发布35项清单,用于规范中毒所致药物诱导QT间期延长和/或尖端扭转型室速(TdP)病例报告与系列报告的最低必备条目。

该指南由临床毒理学协作组(CTC)制定,旨在识别报告中毒所致药物诱导QT间期延长和/或TdP病例时所需的基本和理想标准。方法采用混合方法:先回顾文献中188例已发表的药物诱导QT间期延长和/或TdP中毒病例报告与系列报告,识别常见特征与缺陷;鉴于报告质量存在大量空白,由全部23名CTC成员进行迭代咨询流程,确定基本和理想标准,并制定接受或拒绝个体标准的先验标准。结果调查应答率100%,提供了报告过量场景下QT间期延长和药物诱导TdP病例的最低基本标准集,并呈现一份35项清单。结论认为该QT报告清单可确保已发表的药物诱导QT间期延长中毒病例报告与系列报告能为QT间期延长、TdP及其他恶性心律失常的知识积累做出贡献。

要点

  • 临床毒理学协作组(CTC)制定35项QT报告清单,用于规范中毒所致药物诱导QT间期延长和/或TdP的病例报告与系列报告。
  • 制定前回顾了文献中188例已发表的药物诱导QT间期延长和/或TdP中毒病例报告与系列报告,识别报告常见特征与缺陷。
  • 由全部23名CTC成员进行迭代咨询流程确定基本和理想标准,调查应答率100%。
  • 清单旨在确保病例报告能贡献于QT间期延长、TdP及其他恶性心律失常的知识积累。

适用人群与场景

  • 中毒所致药物诱导QT间期延长和/或TdP的病例报告与系列报告的作者及读者。

研究设计与关键结果

  • 研究类型为指南制定,采用混合方法:先回顾188例已发表的药物诱导QT间期延长和/或TdP中毒病例报告与系列报告,识别常见特征与缺陷;再由全部23名CTC成员进行迭代咨询流程确定基本和理想标准,并制定接受或拒绝个体标准的先验标准。
  • 调查应答率100%,提供报告过量场景下QT间期延长和药物诱导TdP病例的最低基本标准集,并呈现35项清单。

证据类型、等级与局限

  • 证据类型:指南;制定方法为混合方法,包括文献回顾(188例病例报告与系列报告)和23名CTC成员的迭代咨询流程,调查应答率100%。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,采用该35项QT报告清单可确保已发表的药物诱导QT间期延长中毒病例报告与系列报告能为QT间期延长、TdP及其他恶性心律失常的知识积累做出贡献。

指南或共识出处

  • 指南名称:Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose;发布机构:Clinical Toxicology Collaborative (CTC) workgroup;发表期刊:Clin Toxicol (Phila);年份:原文未写明

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: The assessment and management of patients with QT interval prolongation in poisoning requires an appropriate method of measuring and adjusting the QT interval for the heart rate (HR) in order to decide if the patient is at risk of life-threatening dysrhythmias, notably torsade de pointes (TdP). As the Clinical Toxicology Collaborative (CTC) workgroup reviewed the published literature on drug-induced QT interval prolongation in poisoning, it became obvious that many publications were missing essential data that were necessary to thoroughly assess and compare the evidence. The aim of this guidance document is to identify essential and ideal criteria required when reporting a case of drug-induced QT interval prolongation and/or TdP in poisoning.Methods: We employed a mixed methods approach as follows. Initially, we reviewed 188 cases of available published case reports and series in the literature regarding drug-induced QT interval prolongation and/or TdP in poisoning as the first step to another project. Common features and deficiencies were identified. Given the large gaps in reporting quality, we conducted an iterative consultative process involving all 23 members of the CTC to identify essential and ideal criteria to analyse publications of QT interval prolongation in poisoning. A priori standards were developed for acceptance or rejection of individual criteria.Results: Survey response was 100%. A minimum set of essential criteria for reporting cases of QT interval prolongation and drug-induced TdP in overdose setting are provided and a 35-item checklist is presented.Conclusions: We report a QT reporting checklist to ensure published case reports and series describing drug-induced QT interval prolongation in poisoning can contribute to the fund of knowledge of QT interval prolongation, TdP and other malignant dysrhythmias.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Berling I, Hatten BW, Hoffman RS, et al. Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose. Clin Toxicol (Phila). 2019. PMID: 31018700. doi:10.1080/15563650.2019.1605077

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。